Pune, India

Shirish Kumar Kulkarni

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Shirish Kumar Kulkarni

Introduction

Shirish Kumar Kulkarni is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of two patents to his name, Kulkarni's work showcases his dedication to advancing medical science.

Latest Patents

Kulkarni's latest patents include a controlled release pharmaceutical composition of milnacipran. This innovative composition comprises milnacipran or its pharmaceutically acceptable salts along with a hydrophobic release controlling agent. The formulation is designed to release 90% of the total amount of milnacipran over a period of 8 to 20 hours under specific dissolution conditions. His second patent focuses on an antiemetic-oral contraceptive combination, which aims to reduce nausea and vomiting associated with oral contraceptive formulations. This formulation includes progestin and/or estrogen along with an antiemetic, with levonorgestrel being a preferred component.

Career Highlights

Shirish Kumar Kulkarni is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His work at Lupin has allowed him to contribute to the development of innovative drug formulations that address critical health issues.

Collaborations

Kulkarni has collaborated with several professionals in his field, including coworkers Rajesh Kulkarni and Pandharinath Jadhav. These collaborations have likely enhanced the quality and impact of his inventions.

Conclusion

Shirish Kumar Kulkarni's contributions to pharmaceutical innovations reflect his expertise and commitment to improving healthcare solutions. His patents demonstrate a significant advancement in drug formulation technology, which can benefit many patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…